Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000211968 | SCV000167066 | benign | not specified | 2014-04-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000123723 | SCV000213137 | likely benign | Hereditary cancer-predisposing syndrome | 2014-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001085839 | SCV000252943 | likely benign | Ataxia-telangiectasia syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000123723 | SCV000537441 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000211968 | SCV000694198 | likely benign | not specified | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000196069 | SCV001148404 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | ATM: BP7 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000196069 | SCV001469346 | likely benign | not provided | 2021-09-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000196069 | SCV001474785 | likely benign | not provided | 2019-10-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798412 | SCV002043429 | likely benign | Breast and/or ovarian cancer | 2022-10-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000196069 | SCV002048163 | likely benign | not provided | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000123723 | SCV002533353 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-16 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000211968 | SCV004027159 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000196069 | SCV004226228 | uncertain significance | not provided | 2022-07-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589614 | SCV005083851 | benign | Familial cancer of breast | 2024-05-01 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Breakthrough Genomics, |
RCV000196069 | SCV005215747 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001085839 | SCV001461083 | likely benign | Ataxia-telangiectasia syndrome | 2020-04-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000196069 | SCV001808917 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000196069 | SCV001906019 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000196069 | SCV002037359 | likely benign | not provided | no assertion criteria provided | clinical testing |